本文翻译正在准备中。在此之前，我们暂时显示英文原文。
商业 · 2016/2/191 分钟阅读
Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Guidance for Industry on Questions and Answers Regarding the Labeling of Nonprescription Human Drug Products Marketed Without an Approved Application as Required by the Dietary Supplement and Nonprescription Drug Consumer Protection Act
本地自动翻译 · 来源原始语言
摘要
The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995 (the PRA).
来源原始语言: Federal Register — Food and Drug Administration打开原始公告 →